Patents by Inventor Weichuan Mo

Weichuan Mo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230272030
    Abstract: Provided is a fusion protein of insulin and an immunoglobulin Fc region. Specifically, the present invention relates to an insulin fusion protein having a prolonged in vivo half-life and stability, a preparation that contains the fusion protein, a preparation method therefor and an application thereof.
    Type: Application
    Filed: July 19, 2021
    Publication date: August 31, 2023
    Inventors: Yali Wang, Xian Chen, Luyan Zhu, Tingting Zhou, Weichuan Mo, Chengliang Liu, Weiwei Hao, Shuya Wang, Zhaoju Jiang, Zijia Ren, Hongsheng Su
  • Publication number: 20220323590
    Abstract: Provided are a blood coagulation factor IX fusion protein with a prolonged circulation half-life, a conjugate thereof, a pharmaceutical composition containing same and the use of same in treating hemorrhagic diseases (such as hemophilia B).
    Type: Application
    Filed: June 24, 2020
    Publication date: October 13, 2022
    Applicant: JIANGSU GENSCIENCES INC.
    Inventors: Hongsheng SU, Xian CHEN, Weichuan MO, Luyan ZHU, Haixia YAN, Zijia REN, Yali WANG
  • Publication number: 20220000984
    Abstract: Provided by the present invention are a novel GLP-1 fusion protein and a conjugate thereof, a pharmaceutical composition containing same, and a use thereof in reducing blood sugar or body weight, especially for treating diabetes, in particular type II diabetes.
    Type: Application
    Filed: September 25, 2019
    Publication date: January 6, 2022
    Inventors: Yali Wang, Xian Chen, Luyan Zhu, Bin Liu, Xiaoshan Wang, Zijia Ren, Tingting Zhou, Haixia Yan, Yingying Xu, Huihui Gao, Jin Wang, Yang Xu, Yahui Liu, Weichuan Mo, Xin Chen, Jie Gao, Hongsheng Su